Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesEconomicsMedicare Quality Payment Program changes affecting radiology practices for 2025In a new column, Erin Stephens of Healthcare Administrative Partners fdetails the key Medicare Quality Payment program changes that radiology practices need to know about in 2025.Radiation Oncology/TherapyConsolidation reigns in radiation oncologyWomens Imaging'Social capital' tied to more screening mammography uptakeMRIbpMRI, mpMRI show comparable NPV for prostate cancerSponsor ContentElevate your patient's care with the capabilities of Cardiac PET/CT